Rockefeller Capital Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-6,534
| Closed | -$666K | – | 1871 |
|
|
2023
Q2 | $666K | Buy |
6,534
+60
| +0.9% | +$6.12K | ﹤0.01% | 1238 |
|
|
2023
Q1 | $588K | Hold |
6,474
| – | – | ﹤0.01% | 1284 |
|
|
2022
Q4 | $245K | Buy |
6,474
+950
| +17% | +$36K | ﹤0.01% | 1572 |
|
|
2022
Q3 | $138K | Sell |
5,524
-768
| -12% | -$19.2K | ﹤0.01% | 1826 |
|
|
2022
Q2 | $191K | Buy |
6,292
+168
| +3% | +$5.1K | ﹤0.01% | 1658 |
|
|
2022
Q1 | $200K | Buy |
6,124
+4,874
| +390% | +$159K | ﹤0.01% | 1693 |
|
|
2021
Q4 | $32K | Sell |
1,250
-2,189
| -64% | -$56K | ﹤0.01% | 2416 |
|
|
2021
Q3 | $345K | Sell |
3,439
-969
| -22% | -$97.2K | ﹤0.01% | 1392 |
|
|
2021
Q2 | $623K | Buy |
4,408
+2,708
| +159% | +$383K | ﹤0.01% | 1101 |
|
|
2021
Q1 | $169K | Hold |
1,700
| – | – | ﹤0.01% | 1384 |
|
|
2020
Q4 | $210K | Sell |
1,700
-43
| -2% | -$5.31K | ﹤0.01% | 1179 |
|
|
2020
Q3 | $169K | Buy |
1,743
+1,718
| +6,872% | +$167K | ﹤0.01% | 1098 |
|
|
2020
Q2 | $4K | Sell |
25
-16
| -39% | -$2.56K | ﹤0.01% | 2187 |
|
|
2020
Q1 | $6K | Sell |
41
-9
| -18% | -$1.32K | ﹤0.01% | 1922 |
|
|
2019
Q4 | $10K | Hold |
50
| – | – | ﹤0.01% | 1624 |
|
|
2019
Q3 | $4K | Buy |
+50
| New | +$4K | ﹤0.01% | 1705 |
|